Cash and Short Term Investments (Quarterly) Chart

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2025. Start Trial.
Date Value
June 30, 2026 31.49M
March 31, 2026 46.03M
December 31, 2025 44.34M
Date Value
September 30, 2025 54.78M
June 30, 2025 71.77M
March 31, 2025 84.00M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Anavex Life Sciences Corp. 118.33M
Vaxcyte, Inc. 1.292B
Foghorn Therapeutics, Inc. --
Caribou Biosciences, Inc. 94.80M
Arrowhead Pharmaceuticals, Inc. 1.602B